Corporate Finance

BlackRock TCP Capital and MidCap Financial cut dividends by half in late February 2026 as Middle East tensions sparked private credit market stress. Gold surged past $5,250 while equity markets sold off broadly, coinciding with OpenAI's $110B fundraise and Paramount-Warner Bros. Discovery merger discussions.

OpenAI expects to consume $115 billion in capital through 2029, with cash generation not anticipated until 2030. The company plans $1.4 trillion in infrastructure spending over the coming years, raising questions about the financial viability of frontier AI development.

HPE and Juniper launched AI-optimized network infrastructure at MWC 2026, targeting service providers racing to support AI workload demands. The companies introduced cloud-native routers and high-density platforms alongside new financing models to lower adoption barriers as enterprise datacenter costs escalate.

Goldman Sachs acquired two alternative investment firms while selling its Polish fund business, raising its dividend 12.5% as shares climbed 20.5% in six months. Citigroup exited Russia and reduced Mexican holdings while launching three private credit partnerships worth over $105B combined, following 20,000 job cuts announced in early 2024.

S-AI has partnered with Accenture, Palantir, Dell Technologies, and NVIDIA to build sovereign AI infrastructure for nations prioritizing digital and economic security. The alliance aims to establish domestic AI capabilities as governments seek alternatives to foreign-controlled AI systems.

Bank of Montreal's shift away from AIR MILES to a proprietary loyalty program threatens to reduce the Canadian program's transaction volume by up to a quarter over the next two years. The move directly impacts Diversified Royalty Corp, which owns AIR MILES through AM Royalties Limited Partnership and depends on transaction-based royalty streams.

Meta awarded AMD a data center GPU contract valued at double-digit billions per gigawatt, driving AMD shares up 7%. The deal signals cost optimization is reshaping competition in AI infrastructure, where hyperscalers face trillion-dollar buildout expenses.

Vireo Growth's acquisition of Scotts Miracle-Gro's Hawthorne cannabis cultivation business and Eaze delivery platform creates high-probability catastrophic regulatory exposure across multiple state jurisdictions. Federal cannabis prohibition conflicts with state-level legalization, forcing acquirers to navigate 38 different state regulatory frameworks simultaneously. Compliance costs for multi-state cannabis operators now average $3-5 million annually per state license.

Astrana Health filed Form 12b-25 on March 1, 2026, delaying its annual 10-K due to material weaknesses in internal controls discovered during the integration of Prospect Health, acquired June 30, 2025. The disclosure raises concerns about integration execution and potential goodwill impairment on the acquisition.

Multiple commercial real estate operators are restructuring balance sheets ahead of concentrated 2026 debt maturities, with hospitality REITs simultaneously reporting double-digit RevPAR gains. Pebblebrook Hotel Trust posted 4.6% January RevPAR growth while managing refinancing pressure. The sector is consolidating through the Compass-Anywhere merger as operators divest non-core assets.

Three major mortgage REIT platforms executed sequential M&A deals worth $2.8 billion between August 2025 and February 2026, signaling accelerated consolidation in specialty finance. Franklin BSP, Nuveen Churchill, and CoreVest restructured operations through IPOs, acquisitions, and capital raises as interest rate shifts force scale efficiencies.

Real estate investment trusts are deploying equity raises and asset sales to address concentrated 2026 debt maturities, with healthcare operator CHCT selling behavioral health facilities while apartment REIT Mid-America taps equity markets. Hospitality REITs like Pebblebrook posted 37.9% RevPAR gains in San Francisco, signaling uneven sector recovery as companies rebalance portfolios ahead of refinancing deadlines.

Artiva Biotherapeutics, a micro-cap biotech developing natural killer cell therapies, may lack sufficient capital to complete pivotal clinical trials. The going-concern risk highlights funding challenges facing small-cap biotechs pursuing complex cell therapy platforms across autoimmune and oncology indications. Capital adequacy concerns could force dilutive financing or strategic alternatives.

Invesco Mortgage Capital Inc. maintains $5.4 billion in repurchase agreement borrowings, exposing the mortgage REIT to rollover risk if repo markets tighten. The company faces potential forced asset sales at unfavorable prices should lenders increase haircut requirements or withdraw funding.

AMD increased its MI300 AI accelerator revenue forecast to double-digit billions and launched the MI350 series targeting enterprise data centers. Meta Platforms committed to deploy AMD processors worth double-digit billion dollars per gigawatt of data center capacity, validating enterprise AI infrastructure demand.

Cardiff Oncology faces critical liquidity pressure with $60.6M in cash and a quarterly burn rate of $12M, giving the clinical-stage biotech approximately five quarters of runway into Q1 2027. Annual operating losses of $41.1M create immediate financing pressure as the company develops PLK1 inhibitor cancer therapies.

Cardiff Oncology's Q1 2026 pivotal trial data for RAS-mutated colorectal cancer treatment carries catastrophic downside risk, with failure to meet FDA endpoints threatening the company's core development program. CEO Mark Erlander's oncology pipeline faces medium-probability regulatory rejection that could wipe out investor confidence in the biotech's market approval pathway.

Franklin BSP executed three major transactions in Q3 2024—an IPO via Nuveen Churchill, the NewPoint Holdings acquisition, and quarterly earnings across multiple mortgage REIT entities—signaling accelerated consolidation in the $1.7 trillion private credit market. The moves position larger alternative asset managers to absorb specialized lending platforms as regulatory pressure and capital requirements favor scale.

Aerospace component suppliers reported commercial revenue growth of 13% in Q4 2025, with defense aerospace climbing 20% and gas turbine sales jumping 32%. The multi-sector strength reflects sustained post-pandemic fleet renewal demand and accelerating defense modernization spending, with component pricing remaining stable despite broader inflation concerns.

Bank of Montreal's departure from the AIR MILES Reward Program in 2026 will eliminate a significant revenue source for Diversified Royalty Corp., which owns the loyalty program through AM Royalties Limited Partnership. The bank serves as both major program participant and guarantor/financier of the partnership structure, making the transition particularly consequential for royalty income and dividend sustainability.